• Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use
Friday, July 11, 2025
32 °c
Agartala
enewstime
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    Hockey India names 33-man core group for senior men's national camp

    Hockey India names 33-man core group for senior men's national camp

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Red Bull sack F1 team principal Christian Horner

    Red Bull sack F1 team principal Christian Horner

    Stuart Broad labels Australia’s current top three 'the most muddled'

    Stuart Broad labels Australia’s current top three 'the most muddled'

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    'I have asked him for some tips..': Reddy credits Cummins’ advice for bowling success at Lord’s

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    3rd Test: Rotation of bowlers will be a critical thing, says Mel Jones

    Hockey India names 33-man core group for senior men's national camp

    Hockey India names 33-man core group for senior men's national camp

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Bengaluru to host Indian Open Para Athletics Championship on July 11–12

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Club WC: Enrique motivates PSG to 'make history' after routing Real Madrid

    Red Bull sack F1 team principal Christian Horner

    Red Bull sack F1 team principal Christian Horner

    Stuart Broad labels Australia’s current top three 'the most muddled'

    Stuart Broad labels Australia’s current top three 'the most muddled'

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

    NZ opener Allen ruled out of Zimbabwe tri-series with foot injury

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
enewstime
  • Home
  • News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders
Home Health

Study reveals obesity drug may decrease type 2 diabetes risk

ENEWSTIME Desk by ENEWSTIME Desk
September 12, 2022
in Health
30
VIEWS
Share on FacebookShare on Twitter

The risk of type 2 diabetes is more than halved by weekly injections of the new obesity drug semaglutide, which was recently approved in the US and has been provisionally approved in England, says a new study.

The researchers of the study, to be presented at the annual meeting of the European Association for the Study of Diabetes (EASD), said semaglutide reduces the future risk of diabetes by over 60 per cent in patients with obesity.

“Semaglutide appears to be the most effective medication to date for treating obesity and is beginning to close the gap with the amount of weight loss following bariatric surgery,” said researcher W. Timothy Garvey from the University of Alabama at Birmingham in the US.

Obesity is known to increase the risk of type 2 diabetes at least six-fold and the team was interested in understanding whether semaglutide could reduce this risk. To learn more, they conducted a new analysis of the data from two trials of semaglutide.

In STEP 1, 1,961 overweight or obese participants received an injection of 2.4 mg of semaglutide or a placebo weekly, for 68 weeks.

STEP 4 involved 803 participants with overweight or obesity. All received weekly injections of 2.4 mg semaglutide for 20 weeks. They then either remained on semaglutide or were switched to placebo for the next 48 weeks.

In STEP 1 participants receiving semaglutide, 10-year risk scores for type 2 diabetes decreased by 61 per cent (from 18.2 per cent at week 0 to 7.1 per cent at week 68). This compares to a 13 per cent reduction in risk score for those given the placebo (17.8 per cent at week +0 to 15.6 per cent at week 68).

In the STEP 4 participants, the largest decreases in risk scores were seen in the first 20 weeks (from 20.6 per cent at week 0 to 11.4 per cent at week 20). In those who continued receiving semaglutide, the risk score decreased further to 7.7 per cent but in those who were switched to placebo, it rose to 15.4 per cent.

Related Posts

World Population Day: Planned parenthood key for better maternal, child health, says Nadda
Health

World Population Day: Planned parenthood key for better maternal, child health, says Nadda

July 11, 2025
Microsoft’s new AI system to help decode protein motion, advance drug discovery: Satya Nadella
Health

Microsoft’s new AI system to help decode protein motion, advance drug discovery: Satya Nadella

July 11, 2025
From farms to factories: How Tamil Nadu’s incubation hubs are boosting rural livelihoods
Health

From farms to factories: How Tamil Nadu’s incubation hubs are boosting rural livelihoods

July 11, 2025
Disability services must include health screening, stress management for caregivers: Study
Health

Disability services must include health screening, stress management for caregivers: Study

July 10, 2025
Former Telangana CM KCR again admitted to hospital
Health

Former Telangana CM KCR again admitted to hospital

July 10, 2025
Diabetes may raise infection, blood clot risk post knee replacement surgery: Study
Health

Diabetes may raise infection, blood clot risk post knee replacement surgery: Study

July 10, 2025
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
D-2050 D-2050 D-2050
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

About us

Enewstime.in is run by an individual – a Journalist by profession of Tripura with the active help of several journos including senior journalists of the State. On top of that, Enewstime.in being a subscriber of IANS news agency, we have plenty of multi-choice topics to offer to our esteemed readers. Enewstime.in is a venture reach global audience from a tiny State Tripura.

Latest News

Awami League Slams ICT Alleging Coercion of Ex-IGP to Testify Against Hasina

Bloodshed in West Bengal’s Bhangar returns

World Population Day: Planned parenthood key for better maternal, child health, says Nadda

Anupam Kher on President watching ‘Tanvi The Great’: She’s the epitome of different but no less

Income Tax Dept releases excel utilities for ITR-2 and ITR-3 forms

3rd Test: Pope has his 'fingers crossed' as Stokes battles injury at Lord’s

Contact us

19, Old Thana Road. Banamalipur. PO. Agartala. Pin code 799001. Tripura (West), India.

Email: enewstime2017@gmail.com

Wa: 8794548041

  • Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use

© 2025 Designed & Developed with ❤️ by Provibe Media LLP

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders

© 2025 Designed & Developed with ❤️ by Provibe Media LLP